Proxy adviser ISS recommends against Pfizer executive pay proposal
Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation at its ...
Proxy adviser ISS recommends Pfizer shareholders reject executive compensation proposal
Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation due to ...
European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Feds probe disputed tip Pfizer held Covid vaccine results until after 2020 vote: WSJ
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
Pfizer Stock Slips After Report on Vaccine Timing Probe
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
Explore more
Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Former Pfizer R&D Chief Mikael Dolsten Joins Formation Bio to Chair Drug Picking Committee and Co-Chair its Investment Advisory Committee
Formation Bio, an AI-driven pharmaceutical company revolutionizing drug development, today announced that Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President, Pfizer Research & ...
GlobalData on MSN1d
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK
Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
The Daily Signal21hOpinion
Pfizer COVID-19 Bombshell Puts 2020 Election Into Context
Pfizer delayed the announcement of its COVID-19 vaccine until after the 2020 election when it thought Donald Trump was ...
PharmExec11h
Pfizer and Flagship Pioneering Partner to Use AI-Powered Platform for New Drug Development
One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...
Why Pfizer Is My Largest Healthcare Position
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...